BWM
ABBV icon

Boyd Wealth Management’s AbbVie ABBV Stock Holding History

Boyd Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,140
Closed -$248K – 48
2026
Q1 		$248K Hold
1,140
– – 0.1% 46
2025
Q4 		$261K Hold
1,140
– – 0.11% 44
2025
Q3 		$264K Sell
1,140
-47
-4% -$9.57K 0.11% 45
2025
Q2 		$220K Hold
1,187
– – 0.1% 50
2025
Q1 		$249K Hold
1,187
– – 0.12% 41
2024
Q4 		$211K Buy
+1,187
New +$218K 0.1% 47

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Boyd Wealth Management's ABBV Position: Q2 2026 in Review

Boyd Wealth Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,140 shares — an estimated $248K sold.

Boyd Wealth Management first reported a position in ABBV in Q4 2024 and held it in 6 quarters. The position peaked at $264K in Q3 2025. 921 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Boyd Wealth Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Boyd Wealth Management sold 1,140 AbbVie shares in Q2 2026, an estimated $248K.
  • Boyd Wealth Management first reported a position in AbbVie in Q4 2024 and held it in 6 quarters.
  • Boyd Wealth Management's AbbVie position peaked at $264K in Q3 2025.
  • 921 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Boyd Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.